Matteo Levisetti's Insider Trades & SAST Disclosures
Matteo Levisetti's most recent trade in Cue Biopharma Inc was a trade of 250,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Matteo Levisetti.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma Inc | Matteo Levisetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Matteo Levisetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Matteo Levisetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 260,000 | 260,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Levisetti Matteo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Matteo Levisetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 82,500 | 82,500 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Matteo Levisetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 110,000 | 110,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges